ArticleMolecular therapy. Nucleic acids2026

Engineered CRISPR-Cas13a system with enhanced target RNA cleavage activity and reduced collateral activity for therapeutic applications.

Wenxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.